Dorsey & Whitney Trust’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Dorsey & Whitney Trust’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,516	Closed	-$282K	–	609
2022 Q4	$282K	Buy	+2,516	New	+$209K	0.03%	427
2022 Q3	–	Sell	-2,633	Closed	-$211K	–	580
2022 Q2	$211K	Buy	2,633 +25	+1%	+$2.37K	0.02%	496
2022 Q1	$274K	Sell	2,608 -7	-0.3%	-$682	0.02%	451
2021 Q4	$282K	Sell	2,615 -186	-7%	-$20.3K	0.02%	421
2021 Q3	$307K	Sell	2,801 -6	-0.2%	-$623	0.03%	394
2021 Q2	$263K	Sell	2,807 -30	-1%	-$2.76K	0.03%	434
2021 Q1	$262K	Buy	+2,837	New	+$239K	0.03%	423

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dorsey & Whitney Trust's HZNP Position: Q1 2023 in Review

Dorsey & Whitney Trust sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 2,516 shares — an estimated $282K sold.

Dorsey & Whitney Trust first reported a position in HZNP in Q1 2021 and held it in 7 quarters. The position peaked at $307K in Q3 2021. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Dorsey & Whitney Trust reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Dorsey & Whitney Trust sold 2,516 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $282K.
Dorsey & Whitney Trust first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 7 quarters.
Dorsey & Whitney Trust's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $307K in Q3 2021.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2023, filed 11 May 2023.